Skip to content

Outpatient Preoperative Parenteral Nutrition in Malnourished Surgical Patients

Outpatient Preoperative Parenteral Nutrition in Malnourished Surgical Patients: A Feasibility Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03926949
Acronym
OPPortuNity
Enrollment
13
Registered
2019-04-25
Start date
2019-10-30
Completion date
2026-07-31
Last updated
2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malnutrition, Surgery

Brief summary

Malnutrition is common in surgical patients. Many studies have shown a clear association between malnutrition and poor surgical outcomes. Parenteral nutrition (PN) is a nutrition intervention that is given by vein and can be safely provided to malnourished patients. It contains carbohydrates, fats, and protein just like you would normally in your diet. Pre-operative PN is able to improve outcomes in surgical patients. However, pre-operative PN has traditionally required hospital admission which results in increased length of stay, hospital cost, and hospital-acquired infection. Moreover, in hospital pre-operative PN may not be feasible or prioritized when access to inpatient surgery beds is limited. Outpatient PN provides the opportunity to solve this problem. The feasibility and impact of outpatient PN in malnourished patients undergoing major surgery have not previously been studied. This study aims to evaluate the feasibility of outpatient pre-operative PN and its effect on patient's outcomes.

Interventions

OTHERParenteral Nutrition

Olimel 7.6% E 1000 ml will be infused over 4-5 hours at outpatient infusion clinic for 5-10 days within 14 days prior to surgery.

OTHERStandard Nutrition Care

Participants will receive nutrition therapy by registered dietitians within 14 days prior to surgery. Patients with SGA B and SGA C will receive advanced nutrition care and specialized nutrition care, respectively.

Sponsors

University of Alberta
Lead SponsorOTHER
Baxter Healthcare Corporation
CollaboratorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients 18 years of age or older 2. Patients screened at risk of malnutrition by Canadian Nutrition Screening Tool (CNST) and identified as malnourished by subjective global assessment (SGA) B or C

Exclusion criteria

1. Patients undergoing minor or laparoscopic surgery 2. Pregnancy 3. Patients with severe systemic diseases defined by American Society of Anesthesiologists (ASA) classification III to V 4. Patients with diabetes mellitus 5. Patients with planned palliative treatment

Design outcomes

Primary

MeasureTime frameDescription
Rate of parenteral nutrition completionthrough study completion, an average of 1 yearRate of parenteral nutrition completion calculated by the number of patients who can complete parenteral nutrition before surgery for 5-10 days divided by total number of patients in parenteral nutrition group
Postoperative complications evaluated by Clavien-Dindo Classificationthrough study completion, an average of 1 yearClavien-Dindo Classification classifies postoperative complications into 5 grades (grade I to grade V) from mild to severe complications Grade I: no need specific intervention Grade II: need phamacological treatment Grade III: need surgical/endoscopic/radiological intervention Grade IV: life-threatening complications requiring ICU managment Grade V: death of a patient

Secondary

MeasureTime frameDescription
Length of hospital staythrough study completion, an average of 1 yearDuration between hospital admission to discharge
Quality of life: Short Form (SF)-12 questionnaire5-10 days during parenteral nutrition infusionQuality of life evaluated by Short Form (SF)-12 questionnaire A mental component score (MCS-12) and a physical component score (PCS-12) are calculated by summation of mental and physical questions, respectively. The score range from 0-100, which the higher score means the better quality of life.
Body weight5-10 days during parenteral nutrition infusionBody weight measurement in kilograms
Nutrition status5-10 days during parenteral nutrition infusionNutrition status evaluated by patient-generated subjective global assessment Patient-generated subjective global assessment divides a patient into 3 groups: A = well-nourished B = moderately malnourished or suspected malnutrition C = severely malnourished The total score is also calculated by summation of scores from weight, food intake, gastrointestinal symptoms, activity, metabolic demand, and physical examination. It ranges from 0-55, which the lower score means the better nutrition status.
Muscle power5-10 days during parenteral nutrition infusionMuscle power evaluated by handgrip strength test
Cost-savingthrough study completion, an average of 1 yearDifference in total length of stay (primary length of stay plus length of stay during readmission) between 2 groups multiplies by estimated unit cost of inpatient hospital stay per day from Alberta Health Service
Hospital readmission30 days after dischargeReadmission rate within 30 days after discharge
Total energy from parenteral nutrition5-10 days during parenteral nutrition infusionTotal energy from parenteral nutrition measured by total energy in kilocalories per day multiply by total days of parenteral nutrition
Total protein from parenteral nutrition5-10 days during parenteral nutrition infusionTotal protein from parenteral nutrition measured by total protein in grams per day multiply by total days of parenteral nutrition
Acceptability, appropriateness, and feasibility of intervention measured by Acceptability, Appropriateness, and Feasibility Questionnairethrough study completion, an average of 1 yearAcceptability, Appropriateness, and Feasibility Questionnaire included score 1 to 5 1. completely disagree with intervention 2. disagree with intervention 3. neither agree nor disagree with intervention 4. agree with intervention 5. completely agree with intervention

Countries

Canada

Contacts

PRINCIPAL_INVESTIGATORLeah Gramlich, MD

University of Alberta

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026